{"organizations": [], "uuid": "12684198a9020cfe277c371eeef11add8a1bddd9", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/alexion-pharms-elliott-management/alexion-elliott-to-jointly-look-for-new-director-idUSL4N1OX33Q", "country": "US", "domain_rank": 408, "title": "Alexion, Elliott to jointly look for new director", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-02T23:23:00.000+02:00", "replies_count": 0, "uuid": "12684198a9020cfe277c371eeef11add8a1bddd9"}, "author": "", "url": "https://www.reuters.com/article/alexion-pharms-elliott-management/alexion-elliott-to-jointly-look-for-new-director-idUSL4N1OX33Q", "ord_in_thread": 0, "title": "Alexion, Elliott to jointly look for new director", "locations": [], "entities": {"persons": [{"name": "elliott", "sentiment": "negative"}, {"name": "manas mishra", "sentiment": "none"}, {"name": "shounak dasgupta", "sentiment": "none"}], "locations": [{"name": "bengaluru", "sentiment": "none"}], "organizations": [{"name": "reuters staff", "sentiment": "negative"}, {"name": "alexion", "sentiment": "negative"}, {"name": "elliott management", "sentiment": "none"}, {"name": "new york times", "sentiment": "none"}, {"name": "alexion pharmaceuticals inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 24 PM / in 7 minutes Alexion, Elliott to jointly look for new director Reuters Staff 1 Min Read \nJan 2 (Reuters) - Alexion Pharmaceuticals Inc said on Tuesday it had agreed to work with hedge fund Elliott Management to identify a new member to join the drugmakerâ€™s board. \nElliott, which has built a stake in Alexion, is urging the company to take more action to boost its stock price, including exploring a sale, the New York Times reported last month. (Reporting by Manas Mishra in Bengaluru; Editing by Shounak Dasgupta)", "external_links": [], "published": "2018-01-02T23:23:00.000+02:00", "crawled": "2018-01-02T23:34:54.010+02:00", "highlightTitle": ""}